BACKGROUND AND PURPOSE: Lipocalin-2 is a pro-inflammatory adipokine up-regulated in obese human subjects and animal models. Its circulating levels are positively correlated with the unfavourable lipid profiles, elevated blood pressure and insulin resistance index. Augmented lipocalin-2 has been found in patients with cardiovascular abnormalities.The present study was designed to investigate the role of lipocalin-2 in regulating endothelial function and vascular reactivity. EXPERIMENTAL APPROACH: Wild-type and lipocalin-2 knockout (Lcn2-KO) mice were fed with either a standard chow or a high-fat diet. Blood pressures and endothelium-dependent relaxations/contractions were monitored at 2 week intervals. RESULTS: Systolic blood pressure was elevated by high-fat diet in wild-type mice but not in Lcn2-KO mice. Endothelial dysfunction, reflected by the impaired endothelium-dependent relaxations to insulin and augmented endothelium-dependent contractions to ACh, was induced by high-fat diet in wild-type mice. In contrast, Lcn2-KO mice were largely protected from the deterioration of endothelial function caused by dietary challenges. The eNOS dimer/monomer ratio, NO bioavailability, basal and insulin-stimulated PKB/eNOS phosphorylation responses were higher in aortae of Lcn2-KO mice. Administration of lipocalin-2 attenuated endothelium-dependent relaxations to insulin and promoted endothelium-dependent contractions to ACh. It induced eNOS uncoupling and elevated COX expression in the arteries. Treatment with sulphaphenazole, a selective inhibitor of cytochrome P450 2C9, improved endothelial function in wild-type mice and blocked the effects of lipocalin-2 on both endothelium-dependent relaxations to insulin and endothelium-dependent contractions to ACh, as well as eNOS uncoupling. CONCLUSIONS: Lipocalin-2, by modulating cytochrome P450 2C9 activity, is critically involved in diet-induced endothelial dysfunction.
BACKGROUND AND PURPOSE:Lipocalin-2 is a pro-inflammatory adipokine up-regulated in obesehuman subjects and animal models. Its circulating levels are positively correlated with the unfavourable lipid profiles, elevated blood pressure and insulin resistance index. Augmented lipocalin-2 has been found in patients with cardiovascular abnormalities.The present study was designed to investigate the role of lipocalin-2 in regulating endothelial function and vascular reactivity. EXPERIMENTAL APPROACH: Wild-type and lipocalin-2 knockout (Lcn2-KO) mice were fed with either a standard chow or a high-fat diet. Blood pressures and endothelium-dependent relaxations/contractions were monitored at 2 week intervals. RESULTS: Systolic blood pressure was elevated by high-fat diet in wild-type mice but not in Lcn2-KO mice. Endothelial dysfunction, reflected by the impaired endothelium-dependent relaxations to insulin and augmented endothelium-dependent contractions to ACh, was induced by high-fat diet in wild-type mice. In contrast, Lcn2-KO mice were largely protected from the deterioration of endothelial function caused by dietary challenges. The eNOS dimer/monomer ratio, NO bioavailability, basal and insulin-stimulated PKB/eNOS phosphorylation responses were higher in aortae of Lcn2-KO mice. Administration of lipocalin-2 attenuated endothelium-dependent relaxations to insulin and promoted endothelium-dependent contractions to ACh. It induced eNOS uncoupling and elevated COX expression in the arteries. Treatment with sulphaphenazole, a selective inhibitor of cytochrome P450 2C9, improved endothelial function in wild-type mice and blocked the effects of lipocalin-2 on both endothelium-dependent relaxations to insulin and endothelium-dependent contractions to ACh, as well as eNOS uncoupling. CONCLUSIONS:Lipocalin-2, by modulating cytochrome P450 2C9 activity, is critically involved in diet-induced endothelial dysfunction.
Authors: N Ouchi; S Kihara; Y Arita; Y Okamoto; K Maeda; H Kuriyama; K Hotta; M Nishida; M Takahashi; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa Journal: Circulation Date: 2000-09-12 Impact factor: 29.690
Authors: J M Moreno-Navarrete; M Manco; J Ibáñez; E García-Fuentes; F Ortega; E Gorostiaga; J Vendrell; M Izquierdo; C Martínez; G Nolfe; W Ricart; G Mingrone; F Tinahones; J M Fernández-Real Journal: Int J Obes (Lond) Date: 2009-12-01 Impact factor: 5.095
Authors: V Catalán; J Gómez-Ambrosi; A Rodríguez; B Ramírez; C Silva; F Rotellar; M J Gil; J A Cienfuegos; J Salvador; G Frühbeck Journal: J Mol Med (Berl) Date: 2009-05-23 Impact factor: 4.599
Authors: Ivy K M Law; Aimin Xu; Karen S L Lam; Thorsten Berger; Tak W Mak; Paul M Vanhoutte; Jacky T C Liu; Gary Sweeney; Mingyan Zhou; Bo Yang; Yu Wang Journal: Diabetes Date: 2010-01-12 Impact factor: 9.461
Authors: Kristoffer Rosenstand; Kenneth Andersen; Rasmus Terp; Peter Gennemark; Ditte Gry Ellman; Anna Reznichenko; Kate Lykke Lambertsen; Paul M Vanhoutte; Pernille B L Hansen; Per Svenningsen Journal: J Physiol Biochem Date: 2020-02-03 Impact factor: 4.158
Authors: Vishal Singh; Sarah Galla; Rachel M Golonka; Andrew D Patterson; Benoit Chassaing; Bina Joe; Matam Vijay-Kumar Journal: Physiol Genomics Date: 2020-07-06 Impact factor: 3.107
Authors: Bo Yang; Pengcheng Fan; Aimin Xu; Karen Sl Lam; Thorsten Berger; Tak W Mak; Hung-Fat Tse; Jessie Ws Yue; Erfei Song; Paul M Vanhoutte; Gary Sweeney; Yu Wang Journal: Am J Transl Res Date: 2012-01-05 Impact factor: 4.060
Authors: Erfei Song; Sofhia V Ramos; Xiaojing Huang; Ying Liu; Amy Botta; Hye Kyoung Sung; Patrick C Turnbull; Michael B Wheeler; Thorsten Berger; Derek J Wilson; Christopher G R Perry; Tak W Mak; Gary Sweeney Journal: Proc Natl Acad Sci U S A Date: 2018-01-29 Impact factor: 11.205
Authors: Erfei Song; James Ws Jahng; Lisa P Chong; Hye K Sung; Meng Han; Cuiting Luo; Donghai Wu; Stellar Boo; Boris Hinz; Matthew A Cooper; Avril Ab Robertson; Thorsten Berger; Tak W Mak; Isaac George; P Christian Schulze; Yu Wang; Aimin Xu; Gary Sweeney Journal: Am J Transl Res Date: 2017-06-15 Impact factor: 4.060
Authors: Wai Yan Sun; Bo Bai; Cuiting Luo; Kangmin Yang; Dahui Li; Donghai Wu; Michel Félétou; Nicole Villeneuve; Yang Zhou; Junwei Yang; Aimin Xu; Paul M Vanhoutte; Yu Wang Journal: JCI Insight Date: 2018-09-06